7.16
-0.03
(-0.49%)
As of 8:28:32 AM GMT+1. Market Open.
Breakdown
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Assets
231,123.55
193,713.56
143,949.54
108,567.57
Total Liabilities Net Minority Interest
28,112.18
29,082.41
18,390.49
9,830.14
Total Equity Gross Minority Interest
203,011.37
164,631.14
125,559.04
98,737.43
Total Capitalization
203,011.37
164,631.14
125,559.04
98,737.43
Common Stock Equity
203,011.37
164,631.14
125,559.04
98,737.43
Capital Lease Obligations
879.78
999.87
1,256.53
1,303.47
Net Tangible Assets
202,826.34
164,446.11
125,374.01
98,552.40
Working Capital
196,851.65
164,123.09
126,850.36
94,141.26
Invested Capital
203,011.37
164,631.14
125,559.04
98,737.43
Tangible Book Value
202,826.34
164,446.11
125,374.01
98,552.40
Total Debt
879.78
999.87
1,256.53
1,303.47
Share Issued
50,077.78
49,410.34
49,410.34
49,410.34
Ordinary Shares Number
50,077.78
49,410.34
49,410.34
49,410.34
6/30/2021 - 8/16/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PVLA Palvella Therapeutics, Inc.
13.50
+1.43%
GLTO Galecto, Inc.
4.9300
-2.76%
BOLT Bolt Biotherapeutics, Inc.
0.5029
+0.90%
IPSC Century Therapeutics, Inc.
0.8500
+3.13%
PHM.MC Pharma Mar, S.A.
88.05
+3.71%
PULM Pulmatrix, Inc.
7.67
-1.79%
CGEM Cullinan Therapeutics, Inc.
10.98
-2.40%
REPL Replimune Group, Inc.
13.62
-3.20%
IKT Inhibikase Therapeutics, Inc.
1.9200
-31.43%
URGN UroGen Pharma Ltd.
11.35
+3.09%